Harbin Fuerjia Technology Co., Ltd. — Investor Relations & Filings
Harbin Fuerjia Technology Co., Ltd. specializes in the research, development, production, and sale of professional skin care products, with a primary focus on medical dressings and functional cosmetics. The company is widely recognized for its expertise in sodium hyaluronate-based formulations and bioactive materials, including recombinant collagen. Its core product portfolio includes medical-grade repair dressings, facial masks, serums, and gels designed for post-procedural recovery and the management of sensitive skin conditions. By integrating advanced biotechnology with dermatological science, the company serves the medical aesthetics market and the high-end consumer skincare sector. Its operations emphasize rigorous quality control and clinical efficacy, positioning it as a significant provider of professional-grade skin repair solutions.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 2025年年度审计报告 | 2026-04-22 | Chinese | |
| 中信证券股份有限公司关于哈尔滨敷尔佳科技股份有限公司2025年度内部控制评价报告的核查报告 | 2026-04-22 | Chinese | |
| 董事和高级管理人员薪酬管理制度 | 2026-04-22 | Chinese | |
| 关于董事、高级管理人员2026年度薪酬方案的公告 | 2026-04-22 | Chinese | |
| 董事会关于2025年度董事履职与绩效评价及薪酬情况的说明 | 2026-04-22 | Chinese | |
| 未来三年股东回报规划(2026年-2028年) | 2026-04-22 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 39528248 | 2025年年度审计报告 | 2026-04-22 | Chinese | ||
| 39528246 | 中信证券股份有限公司关于哈尔滨敷尔佳科技股份有限公司2025年度内部控制评价报告的核查报告 | 2026-04-22 | Chinese | ||
| 39528244 | 董事和高级管理人员薪酬管理制度 | 2026-04-22 | Chinese | ||
| 39528241 | 关于董事、高级管理人员2026年度薪酬方案的公告 | 2026-04-22 | Chinese | ||
| 39528237 | 董事会关于2025年度董事履职与绩效评价及薪酬情况的说明 | 2026-04-22 | Chinese | ||
| 39528232 | 未来三年股东回报规划(2026年-2028年) | 2026-04-22 | Chinese | ||
| 39528230 | 关于2025年度利润分配预案的公告 | 2026-04-22 | Chinese | ||
| 39528228 | 2025年度控股股东及其他关联方资金占用情况的专项说明 | 2026-04-22 | Chinese | ||
| 39528226 | 关于使用闲置自有资金进行委托理财的公告 | 2026-04-22 | Chinese | ||
| 39528223 | 关于续聘会计师事务所的公告 | 2026-04-22 | Chinese | ||
| 39528221 | 2025年度独立董事述职报告(姚淑英) | 2026-04-22 | Chinese | ||
| 39528219 | 2025年度内部控制评价报告 | 2026-04-22 | Chinese | ||
| 39528216 | 关于“质量回报双提升”行动方案的进展公告 | 2026-04-22 | Chinese | ||
| 39528214 | 2025年度监事会工作报告 | 2026-04-22 | Chinese | ||
| 39528211 | 2025年年度报告摘要 | 2026-04-22 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Harbin Fuerjia Technology Co., Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/56273/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=56273 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=56273 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=56273 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 56273}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Harbin Fuerjia Technology Co., Ltd. (id: 56273)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.